Heidrich, B.Yurdaydin, C.Kabacam, G.Zachou, K.Bremer, B.Dalekos, G. N.Erhardt, A.Cakaloglu, Y.Yalcin, K.Zeuzem, S.Bock, T.Idilman, R.Manns, M. P.Wedemeyer, H.2024-08-162024-08-162013-04-010168-8278https://hdl.handle.net/11452/44145Bu çalışma, 01-05, Kasım 2013 tarihleri arasında Washington[ABD]’da düzenlenen 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineGastroenterology & hepatologyLong-term follow-up after peg-ifna2a-based therapy of chronic hepatitis deltaMeeting Abstract000322983000047S20S2058Supplement1, Special IssueSI